Adenovirus Vector-Induced Innate Inflammatory Mediators, MAPK Signaling, As Well As Adaptive Immune Responses Are Dependent upon Both TLR2 and TLR9 In Vivo1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Immunology

• Publication date

  2008-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.181.3.2134PMID 18641352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wild-type adenoviruses from groups A–F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent

  2008cited by this paper
• Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells.

  2007cited by this paper
• Signaling pathways downstream of pattern-recognition receptors and their cross talk.

  2007cited by this paper
• Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.

  2007cited by this paper
• Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors.

  2007cited by this paper
• Role of MyD88 and TLR9 in the Innate Immune Response Elicited by Serotype 5 Adenoviral Vectors

  2007cited by this paper
• Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.

  2007cited by this paper
• Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator

  2007influential reference
• MAPK phosphatases — regulating the immune response

  2007cited by this paper
• Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways

  2007cited by this paper
• Preferential Activation of Toll-Like Receptor Nine by CD46-Utilizing Adenoviruses

  2006cited by this paper
• Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system.

  2006cited by this paper
• Role for TLR2 in NK Cell-Mediated Control of Murine Cytomegalovirus In Vivo

  2006cited by this paper
• Adenovirus Infection Triggers a Rapid, MyD88-Regulated Transcriptome Response Critical to Acute-Phase and Adaptive Immune Responses In Vivo

  2006cited by this paper
• Arrestin-2 and G Protein-coupled Receptor Kinase 5 Interact with NFκB1 p105 and Negatively Regulate Lipopolysaccharide-stimulated ERK1/2 Activation in Macrophages*

  2006cited by this paper
• Coxsackievirus B3 replication is related to activation of the late extracellular signal-regulated kinase (ERK) signal.

  2005cited by this paper
• Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.

  2004cited by this paper
• Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors.

  2003cited by this paper
• A Hemodynamic Response to Intravenous Adenovirus Vector Particles Is Caused by Systemic Kupffer Cell-Mediated Activation of Endothelial Cells

  2003cited by this paper
• Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1

  2003cited by this paper
• Human Cytomegalovirus Activates Inflammatory Cytokine Responses via CD14 and Toll-Like Receptor 2

  2003cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• Liver Toxicities Typically Induced by First-Generation Adenoviral Vectors Can Be Reduced by Use of E1, E2b-Deleted Adenoviral Vectors

  2003cited by this paper
• Construction of first-generation adenoviral vectors.

  2002cited by this paper
• Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10

  2002cited by this paper
• Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

  2001cited by this paper
• Adenovirus Vectors with the 100K Gene Deleted and Their Potential for Multiple Gene Therapy Applications

  2001cited by this paper
• Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus

  2001cited by this paper
• Adenovirus Vector-Induced Expression of the C-X-C Chemokine IP-10 Is Mediated through Capsid-Dependent Activation of NF-κB

  2000cited by this paper
• Persistence of an [E1-, Polymerase-] Adenovirus Vector Despite Transduction of a Neoantigen into Immune-Competent Mice

  1999cited by this paper
• Production and Characterization of Improved Adenovirus Vectors with the E 1 , E 2 b , and E 3 Genes Deleted

  1998cited by this paper
• Production and Characterization of Improved Adenovirus Vectors with the E1, E2b, and E3 Genes Deleted

  1998cited by this paper
• Genomic DNA from mice: a comparison of recovery methods and tissue sources.

  1997cited by this paper
• The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors

  1997cited by this paper
• Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications.

  1994cited by this paper

• Sex Differences in Response to Viral Vector Vaccines—Implications for Future Vaccine Design

  2026cites this paper
• Dendritic cell targeting in lymph nodes with modular adapters boosts HAdV5 and HC-HAdV5 tumor vaccination by co-secretion of IL-2v and IL-21

  2025cites this paper
• COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves’ disease

  2025cites this paper
• Genetic regulation of short chain fatty acid on Leghorn male hepatoma cells infected with Fowl Adenovirus serotype-4.

  2025cites this paper
• TURRITOPSIS SP. ( TSP. ) COULD BE USED TO EXPLORE SYSTEM REJUVENATION, SELF-REPAIR AND REGENERATION HUMAN

  2025cites this paper
• Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human

  2025cites this paper
• Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications

  2024cites this paper
• Vaccine adjuvants for infectious disease in the clinic

  2024cites this paper
• Recent developments in gene therapy research in India

  2024cites this paper
• MVA-based SARS-CoV-2 vaccine candidates encoding different spike protein conformations induce distinct early transcriptional responses which may impact subsequent adaptive immunity

  2024cites this paper
• Adenoviral Vector System: A Comprehensive Overview of Constructions, Therapeutic Applications and Host Responses

  2024cites this paper
• Two Novel Adenovirus Vectors Mediated Differential Antibody Responses via Interferon-α and Natural Killer Cells

  2023cites this paper
• Human adenovirus oncolytic properties and the inhibitory role of E4 orf4 and E4 orf6/7 on endogenously activated NF-κB

  2023cites this paper
• Introns and Their Therapeutic Applications in Biomedical Researches

  2023cites this paper
• Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine

  2023cites this paper
• Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models

  2023cites this paper
• Viral vector vaccines

  2022cites this paper
• Incubation Temperature and Period During Denarase Treatment and Microfiltration Affect the Yield of Recombinant Adenoviral Vectors During Downstream Processing

  2022cites this paper
• Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses

  2022cites this paper
• Cytokine Responses to Adenovirus and Adenovirus Vectors

  2022cites this paper
• NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity

  2022cites this paper
• Pharmaceutical Aspects and Clinical Evaluation of COVID-19 Vaccines

  2021cites this paper
• Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling Pathways

  2021cites this paper
• Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines

  2021cites this paper
• Strategies for Vaccination: Conventional Vaccine Approaches Versus New-Generation Strategies in Combination with Adjuvants

  2021cites this paper
• Adenovirus vector-based vaccine for infectious diseases

  2021cites this paper
• Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases

  2021cites this paper
• Approved and marketed nanoparticles for disease targeting and applications in COVID-19

  2021cites this paper
• Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen

  2021cites this paper
• Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy.

  2021cites this paper
• Adaptive anti-tumor immunity is orchestrated by a population of CCL5-producing tissue-resident NK cells

  2021cites this paper
• A New Look at Vaccine Strategies Against PPRV Focused on Adenoviral Candidates

  2021cites this paper
• Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses

  2021cites this paper
• Advances in Development and Application of Influenza Vaccines

  2021cites this paper
• Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic

  2021cites this paper
• Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization

  2021cites this paper
• Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections

  2021cites this paper
• Current Insights into the Host Immune Response to Respiratory Viral Infections.

  2021cites this paper
• Overcoming innate immune barriers that impede AAV gene therapy vectors.

  2021cites this paper
• The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A

  2021cites this paper
• Correlation Study between Level of zinc and lead in Serum and Seminal Plasma in Infertile Patients

  2020cites this paper
• Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines

  2020cites this paper
• Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines

  2020cites this paper
• Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster

  2020influential citation
• The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses

  2020cites this paper
• Molecular and Structural Basis of DNA Sensors in Antiviral Innate Immunity

  2020cites this paper
• Recombinant Adenovirus Vectors as Mucosal Vaccines

  2020cites this paper
• Oncolytic adenovirus ORCA‐010 increases the type 1 T cell stimulatory capacity of melanoma‐conditioned dendritic cells

  2020cites this paper
• Zeiny Bibi Aubdoollah ALL RIGHTS RESERVED DISTINGUISHING THE ROLE OF INSULIN VS INSULINOMA CELLS AS MODULATORS OF CELL MIGRATION IN A CELL-MEDIATED MODEL OF WOUND HEALING by ZEINY

  2020cites this paper
• Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines

  2020influential citation
• The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.

  2019influential citation
• Targeted Antigen Delivery: Bridging Innate and Adaptive Immunity

  2019cites this paper
• Chapter 4 Adenoviral Vector-Based Vaccines and Gene Therapies : Current Status and Future Prospects

  2019cites this paper
• PROSPECTS OF Toll-LIKE RECEPTOR AGONISTS AND ANTAGONISTS FOR PREVENTION AND TREATMENT OF VIRAL INFECTIONS

  2019cites this paper
• Fowl adenoviruse-4 infection induces strong innate immune responses in chicken.

  2019cites this paper
• Innate immunity to adenovirus: lessons from mice

  2019cites this paper
• Rhoptry antigens as Toxoplasma gondii vaccine target

  2019cites this paper
• Transcriptome analysis of fowl adenovirus serotype 4 infection in chickens

  2019cites this paper
• Exosomes: A Novel Biomarker and Approach to Gene Therapy for Spinal Muscular Atrophy

  2019cites this paper
• Disparate Entry of Adenoviruses Dictates Differential Innate Immune Responses on the Ocular Surface

  2019cites this paper
• Mechanism of fowl adenovirus serotype 4‐induced heart damage and formation of pericardial effusion

  2019cites this paper
• Insights into leghorn male hepatocellular cells response to fowl adenovirus serotype 4 infection by transcriptome analysis.

  2018cites this paper
• 5 Translational Challenges for Hepatocyte-Directed Gene Transfer

  2018cites this paper
• Adenoviral Vector-Based Vaccines and Gene Therapies: Current Status and Future Prospects

  2018cites this paper
• Adenoviral transduction of stem cells: in vitro responses and in vivo immune responses after cell transplantation Cells: In Vitro

  2018cites this paper
• Humoral Responses Elicited by Adenovirus Displaying Epitopes Are Induced Independently of the Infection Process and Shaped by the Toll-Like Receptor/MyD88 Pathway

  2018influential citation
• Development and pre-clinical evaluation of a new HIV-1 vaccine concept

  2018cites this paper
• Enhanced Antitumor Efficacy of Oncolytic Adenovirus–loaded Menstrual Blood–derived Mesenchymal Stem Cells in Combination with Peripheral Blood Mononuclear Cells

  2018cites this paper
• Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages

  2017cites this paper
• Current and Future Treatments for Lysosomal Storage Disorders

  2017cites this paper
• Immunology Causes , Clinical Symptoms , Virology , and Respiratory Viral Infections in Infants :

  2017cites this paper
• RNA-Interferenz-basierte Therapien bei Adenovirusinfektionen im immunsupprimierten Wirt

  2017cites this paper
• Germinal Center B Cell and T Follicular Helper Cell Responses to Viral Vector and Protein-in-Adjuvant Vaccines

  2016cites this paper
• Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment

  2016cites this paper
• In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens

  2016cites this paper
• Long-term, high-level hepatic secretion of acid α-glucosidase for Pompe disease achieved in non-human primates using helper-dependent adenovirus

  2016cites this paper
• Immunological boosting and personalization of oncolytic virotherapies for cancer treatment

  2016cites this paper
• Adenovirus sensing by the immune system.

  2016cites this paper
• Viral vectors as vaccine carriers.

  2016cites this paper
• Role of MyD88 in Adenovirus Keratitis

  2016cites this paper
• TANK-binding kinase 1-dependent or -independent signaling elicits the cell-type-specific innate immune responses induced by the adenovirus vector.

  2016cites this paper
• Immunomodulation Within a Single Tumor Site to Induce Systemic Antitumor Immunity: In Situ Vaccination for Cancer

  2016cites this paper
• New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design

  2016cites this paper
• This information is current as against Extracellular Antigens Improves Adaptive Immune Responses Recombinant Adenovirus Preferentially In Vivo Synthesis of Cyclic-di-GMP Using a

  2016cites this paper
• Methods to Mitigate Immune Responses to Adenoviral Vectors

  2016cites this paper
• Lactobacillus plantarum vaccine vector expressing hemagglutinin provides protection against H9N2 challenge infection.

  2016cites this paper
• Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice.

  2016cites this paper
• Strengthened tumor antigen immune recognition by inclusion of a recombinant Eimeria antigen in therapeutic cancer vaccination

  2015cites this paper
• Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice

  2015cites this paper
• Malaria Transmission Blocking Vaccines

  2015cites this paper
• Development of gene therapy for Niemann-Pick Type C disease

  2015cites this paper
• In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf

  2015cites this paper
• Multifaceted role of β-arrestins in inflammation and disease

  2015cites this paper
• Antiadenovirus drug discovery: potential targets and evaluation methodologies.

  2015cites this paper
• Combining oncolytic immunotherapy with conventional cancer treatments

  2015cites this paper
• Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5–based Constructs

  2015cites this paper
• Sevoflurane exerts a more marked influence compared with propofol on gene expression in patients undergoing coronary artery bypass graft surgery

  2015cites this paper
• Innate Functions of Immunoglobulin M Lessen Liver Gene Transfer with Helper-Dependent Adenovirus

  2014cites this paper
• The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity

  2014cites this paper
• Challenges and Prospects for Helper-Dependent Adenoviral Vector-Mediated Gene Therapy

  2014cites this paper